Novavax Inc

Ownership Transactions Reported by 19 Insiders

Symbol
NVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Quince Orchard Road, Gaithersburg, MD

Insiders trading volume in the past year

Novavax Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John C. Jacobs President and CEO, Director $9.48M Mar 1, 2024
Casey Mark J EVP, Chief Legal Officer $3.72M Dec 11, 2024
James F. Young Director $1.26M -$209K -14.2% Jun 21, 2024
Filip Dubovsky President, R&D $1.23M -$859K -41.2% Jun 17, 2024
Ruxandra Draghia-Akli Section 16 $1.17M Nov 11, 2024
David Mott Director $1.09M Jun 12, 2024
Douglas Richard Director $1M Jun 12, 2024
Elaine O'Hara EVP, Chief Strategy Officer $731K Mar 1, 2024
Rachel King Director $656K Jun 12, 2024
Gregg H. Alton Director $538K Jun 12, 2024
Margaret G. Mcglynn Director $538K Jun 12, 2024
Richard J. Rodgers Director $538K Jun 12, 2024
John Trizzino EVP, CCO and CBO $394K Aug 19, 2024
Stanley C. Erck President and CEO, Director $195K Dec 14, 2022
James Patrick Kelly EVP, CFO and Treasurer $187K Aug 16, 2024
Gregory M. Glenn President, R&D $150K Mar 6, 2023
Gary C. Evans Director $83.3K Jun 17, 2021
John A. Herrmann III EVP, Chief Legal Officer $56.4K Dec 14, 2023
Michael A. Mcmanus Jr Director $43K Jun 16, 2022

Recent Insider Transactions by Companies or Individuals for Novavax Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.